TEVA PHARMACEUTICAL INDUSTRIES LTD
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
Israel
Country
Israel
Business Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV, ,
Mailing Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV, ,
Phone
972 (3) 914-8213
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025 FY
$1.50B
Revenue
$7.91B
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| DEF 14A Definitive proxy statement | March 31, 2026 | View on SEC |
| 4 Insider stock transaction report | March 19, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
| 4 Insider stock transaction report | March 9, 2026 | View on SEC |
Annual Reports
10-K
February 3, 2026
- Successfully reduced and refinanced debt, repaying $1.38 billion and retiring $2.29 billion in bonds, while issuing new notes to extend maturity profiles.
- Received a significant $500 million milestone payment for Duvakitug, an anti-TL1A asset, after initiating Phase 3 studies, highlighting pipeline value.
Insider Trading
STRONG SELL
11 insiders
31 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.